AU2002359403A8 - Methods and compositions for regulation of gene expression through modulation of mrna turnover - Google Patents

Methods and compositions for regulation of gene expression through modulation of mrna turnover

Info

Publication number
AU2002359403A8
AU2002359403A8 AU2002359403A AU2002359403A AU2002359403A8 AU 2002359403 A8 AU2002359403 A8 AU 2002359403A8 AU 2002359403 A AU2002359403 A AU 2002359403A AU 2002359403 A AU2002359403 A AU 2002359403A AU 2002359403 A8 AU2002359403 A8 AU 2002359403A8
Authority
AU
Australia
Prior art keywords
modulation
regulation
compositions
methods
gene expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002359403A
Other versions
AU2002359403A1 (en
Inventor
Michael Karin
Ching-Yi Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of AU2002359403A8 publication Critical patent/AU2002359403A8/en
Publication of AU2002359403A1 publication Critical patent/AU2002359403A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
AU2002359403A 2001-11-15 2002-11-14 METHODS AND COMPOSITIONS FOR REGULATION OF GENE EXPRESSION THROUGH MODULATION OF mRNA TURNOVER Abandoned AU2002359403A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33471201P 2001-11-15 2001-11-15
US60/334,712 2001-11-15
PCT/US2002/036665 WO2003044166A2 (en) 2001-11-15 2002-11-14 METHODS AND COMPOSITIONS FOR REGULATION OF GENE EXPRESSION THROUGH MODULATION OF mRNA TURNOVER

Publications (2)

Publication Number Publication Date
AU2002359403A8 true AU2002359403A8 (en) 2003-06-10
AU2002359403A1 AU2002359403A1 (en) 2003-06-10

Family

ID=23308474

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002359403A Abandoned AU2002359403A1 (en) 2001-11-15 2002-11-14 METHODS AND COMPOSITIONS FOR REGULATION OF GENE EXPRESSION THROUGH MODULATION OF mRNA TURNOVER

Country Status (2)

Country Link
AU (1) AU2002359403A1 (en)
WO (1) WO2003044166A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9085778B2 (en) 2006-05-03 2015-07-21 VL27, Inc. Exosome transfer of nucleic acids to cells
JP5808349B2 (en) 2010-03-01 2015-11-10 カリス ライフ サイエンシズ スウィッツァーランド ホールディングスゲーエムベーハー Biomarkers for theranosis
BR112012025593A2 (en) 2010-04-06 2019-06-25 Caris Life Sciences Luxembourg Holdings circulating biomarkers for disease
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
EP3052616A4 (en) * 2013-10-02 2017-03-29 Paradigm Biopharmaceuticals Limited A method of producing exosomes
BR112017026467A2 (en) 2015-06-10 2018-09-11 Univ Texas use of exosomes to treat disease
CN108715830B (en) * 2018-05-04 2019-08-06 中南大学湘雅医院 Urinate the extracting method and its application of derived stem cell excretion body

Also Published As

Publication number Publication date
AU2002359403A1 (en) 2003-06-10
WO2003044166A2 (en) 2003-05-30
WO2003044166A3 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
HK1068375A1 (en) Method of determining dihydropyrimidine dehydrogenase gene expression
EP1177277A4 (en) Compositions and methods for the modification of gene transcription
AU2002357759A8 (en) Manipulation of cytokine levels using cd83 gene products
EP1443905A4 (en) Compositions for oral gene therapy and methods of using same
HK1085334A1 (en) Methods and devices for controlling distribution of advertisement
PT2174945E (en) Antisense modulation of apolipoprotein b expression
EP1527164A4 (en) Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor
IL160648A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
IL160630A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
IL159368A0 (en) Method of modifying enzyme and oxidoreductase variant
AU2002359403A8 (en) Methods and compositions for regulation of gene expression through modulation of mrna turnover
GB9927191D0 (en) Methods and means for regulation of gene expression
GB0015119D0 (en) Methods and means for regulation of gene expression
GB0101447D0 (en) Regulation of glucocorticoid concentration
EP1163340A4 (en) Compositions and methods for the modification of gene expression
AU3433301A (en) Dehiscence gene and methods for regulating dehiscence
IL126757A0 (en) Regulation of gene expression through manipulation of mRNA splicing and its uses
GB0328781D0 (en) Inhibitors of dna methyltransferase isoforms
HK1056745A1 (en) Transgulatminase gene of streptovertcillium ladakanum and the transglutaminase encoded therefrom
EP1390382A4 (en) Elucidation of gene function
GB0117964D0 (en) Control of gene expression
GB0118201D0 (en) Regulation of gene expression
IL157694A (en) Method of determining dihydropyrimidine dehydrogenase gene expression
AU2002340060A1 (en) Methods of controlling gene expression and gene silencing
ZA200409052B (en) Compositions and methods for the modification of gene expression

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase